Survival Outcomes of Uterine Cervical Malignancies in Chinese Population

NCT03291236 | Unknown

• 1 other identifier: SOCM-1
• Study Type: observational
• Target: 5,000
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary malignancies of uterine cervix in China and relevant risk factors in a prospective cohort study.

Conditions

Uterine Cervical Neoplasms; Survival

Outcome Measures

Primary Outcomes (2)

• Overall survival

  Duration from diagnosis to recurrence

  5 years

• Progression-free survival

  Duration from last treatment after remission to recurrence

  5 years

Interventions

Follow-up for death and recurrence of patients OTHER

All patients are follow-up to determine specific date of diagnosis, recurrence and death.

Eligibility Criteria

• Sex: female
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients with primary malignancies of uterine cervix in China.

You may qualify if:

• Primary malignancies of uterine cervix.

You may not qualify if:

• Secondary malignancies of uternie cervix.

Sponsors & Collaborators

• Lei Li: lead

Study Sites (1)

Lei Li

Beijing, China/Beiing, 100000, China

RECRUITING

Related Publications (1)

• Li L, Ma S, Tan X, Zhong S, Wu M. The Urodynamics and Survival Outcomes of Different Methods of Dissecting the Inferior Hypogastric Plexus in Laparoscopic Nerve-Sparing Radical Hysterectomy of Type C: A Randomized Controlled Study. Ann Surg Oncol. 2019 May;26(5):1560-1568. doi: 10.1245/s10434-019-07228-8. Epub 2019 Feb 13.

  PMID: 30759291 DERIVED

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Interventions

Death Domain

Condition Hierarchy (Ancestors)

Uterine Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Uterine Cervical Diseases; Uterine Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases

Intervention Hierarchy (Ancestors)

Death Domain Superfamily; Protein Interaction Domains and Motifs; Protein Domains; Protein Structural Elements; Protein Conformation; Molecular Conformation; Molecular Structure; Biochemical Phenomena; Chemical Phenomena

Study Officials

• Lei Li, MD

  Peking Union Medical College Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Lei Li, MD

CONTACT

13911988831; lileigh@163.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: September 20, 2017
• First Posted: September 25, 2017
• Study Start: January 1, 2017
• Primary Completion: January 1, 2022
• Study Completion: January 1, 2023
• Last Updated: February 8, 2018

Record last verified: 2018-02

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)